JP2021525787A5 - - Google Patents

Info

Publication number
JP2021525787A5
JP2021525787A5 JP2020568390A JP2020568390A JP2021525787A5 JP 2021525787 A5 JP2021525787 A5 JP 2021525787A5 JP 2020568390 A JP2020568390 A JP 2020568390A JP 2020568390 A JP2020568390 A JP 2020568390A JP 2021525787 A5 JP2021525787 A5 JP 2021525787A5
Authority
JP
Japan
Prior art keywords
approximately
hour
pharmaceutical composition
days
composition according
Prior art date
Application number
JP2020568390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525787A (ja
JPWO2019234240A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/065016 external-priority patent/WO2019234240A1/en
Publication of JP2021525787A publication Critical patent/JP2021525787A/ja
Publication of JPWO2019234240A5 publication Critical patent/JPWO2019234240A5/ja
Publication of JP2021525787A5 publication Critical patent/JP2021525787A5/ja
Priority to JP2024075901A priority Critical patent/JP2024107004A/ja
Pending legal-status Critical Current

Links

JP2020568390A 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用 Pending JP2021525787A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075901A JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862682116P 2018-06-07 2018-06-07
US62/682,116 2018-06-07
US201962804970P 2019-02-13 2019-02-13
US62/804,970 2019-02-13
PCT/EP2019/065016 WO2019234240A1 (en) 2018-06-07 2019-06-07 Combinations of beta-lactam compounds and probenecid and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075901A Division JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Publications (3)

Publication Number Publication Date
JP2021525787A JP2021525787A (ja) 2021-09-27
JPWO2019234240A5 JPWO2019234240A5 (https=) 2022-06-15
JP2021525787A5 true JP2021525787A5 (https=) 2022-06-15

Family

ID=67105981

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020568390A Pending JP2021525787A (ja) 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用
JP2024075901A Pending JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075901A Pending JP2024107004A (ja) 2018-06-07 2024-05-08 β－ラクタム化合物とプロベネシドの組み合わせとその使用

Country Status (8)

Country Link
US (3) US11554112B2 (https=)
EP (1) EP3801486A1 (https=)
JP (2) JP2021525787A (https=)
CN (2) CN112739338A (https=)
AU (1) AU2019281018B2 (https=)
BR (1) BR112020024498A2 (https=)
TW (1) TW202005970A (https=)
WO (1) WO2019234240A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
MX2021009755A (es) 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos.
CA3169900A1 (en) * 2020-03-11 2021-09-16 Iterum Therapeutics International Limited Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
WO2021207606A1 (en) * 2020-04-10 2021-10-14 University Of Georgia Research Foundation, Inc. Methods for treatment of coronavirus infections
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN111840236B (zh) * 2020-08-07 2022-09-02 安徽康正康仁药业有限公司 一种注射用美罗培南丙磺舒钠复方冻干制剂
CN111821462A (zh) * 2020-08-07 2020-10-27 安徽康正康仁药业有限公司 青霉素类钠盐与丙磺舒钠组成的复方冻干制剂
CN112076161B (zh) * 2020-08-07 2022-10-18 安徽康正康仁药业有限公司 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3302335A1 (de) * 1982-01-26 1983-07-28 Leo Pharmaceutical Products Ltd. A/S (Loevens kemiske Fabrik Produktionsaktieselskab), 2750 Ballerup Ss-lactamverbindungen, ihre herstellung und sie enthaltendes arzneimittel
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
UA59394C2 (uk) 1998-03-27 2003-09-15 Каділа Фармацевтікелс (І.Ей) Лтд. Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти)
DE60103299T2 (de) 2000-10-30 2005-05-12 Lupin Ltd., Mumbai Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
WO2002041876A1 (en) 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
AU2002224011B2 (en) 2001-11-19 2008-05-01 Lupin Limited A pharmaceutical composition for controlled release of a beta-lactam antibiotic
CN1853724A (zh) 2004-12-01 2006-11-01 吴晓辉 丙磺舒钠、钾与β－内酰胺类抗生素组成复方针剂及其用途
CN1813700A (zh) 2006-03-01 2006-08-09 吴晓辉 丙磺舒钠与青霉素类抗生素组成复方针剂
ES2355950T3 (es) * 2006-06-28 2011-04-01 Pfizer Products Inc. Profármacos de penem.
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
EP3315124B1 (en) 2009-11-13 2021-01-06 Astrazeneca AB Bilayer tablet formulations
WO2014149789A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv Combination of canagliflozin and probenecid for the treament of hyperuricemia
TR201605632A1 (tr) 2016-04-28 2017-11-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
MX2021009755A (es) 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos.
CA3169900A1 (en) 2020-03-11 2021-09-16 Iterum Therapeutics International Limited Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

Similar Documents

Publication Publication Date Title
JP2021525787A5 (https=)
JP6875454B2 (ja) Ｈｉｖを治療するためのトール様受容体の調節因子
JP5474276B2 (ja) 高脂血症治療剤
RU2018133298A (ru) Способы применения агонистов fxr
CN101959429A (zh) 抗微生物肽系统的激动剂
JP2019515884A5 (https=)
JP2011502997A5 (https=)
JP2022031813A (ja) １５－ｈｅｐｅを含む組成物、およびそれを用いて線維症を処置または防止する方法
JP5470245B2 (ja) バイオフィルム形成の処置のためのトリアゾール化合物
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2021502382A5 (https=)
WO2018226987A1 (en) Compositions for treating fungal and bacterial biofilms and methods of using the same
RU2007107935A (ru) Полисульфатированные гликозиды и их соли
WO2020117755A1 (en) Compositions and methods for treating biofilms
JP2010514734A (ja) 腸障害の治療のためのイソソルビドモノニトレート誘導体
JPWO2019234240A5 (https=)
JP2019521178A5 (https=)
JP2020536098A5 (https=)
JP2008088189A5 (https=)
BR112021005955A2 (pt) agentes e métodos para modular atividade de patógeno
JP2005509663A5 (https=)
US20050227949A1 (en) Compositions and methods for treatment of viral and bacterial infections
JP4380967B2 (ja) ウイルス性心筋炎の予防または治療剤
JP4796258B2 (ja) クラミジア・ニューモニエ感染症の治療に有用な医薬組成物を製造するためのチアムフェニコール及びその誘導体の使用
RU2025130451A (ru) Фармацевтическая композиция для лечения воспалительного заболевания кишечника